Leveraging mRNA technology for antigen based immuno-oncology therapies

Leveraging mRNA technology for antigen based immuno-oncology therapies

The application of messenger RNA (mRNA) technology in antigen-based immuno-oncology therapies represents a significant advancement in cancer treatment. Cancer vaccines are an effective combinatorial partner to sensitize the host immune system to the tumor and boost the efficacy of immune therapies....

Full description

Saved in:

Bibliographic Details
Main Authors:	Wei Zheng, Michele Ceccarelli, Charalampos S Floudas, Siranush Sarkizova
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-01-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/1/e010569.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

mRNA vaccines as cancer therapies
by: Shaoxiong Huang, et al.
Published: (2024-12-01)

Nuclear mRNA export
by: Chen Suli, et al.
Published: (2024-09-01)

Revolutionizing solid tumor treatments: The rise of immuno-oncology innovations in 2024
by: Gokul Sudhakaran, et al.
Published: (2024-06-01)

Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells
by: Stefanie Hoyer, et al.
Published: (2015-01-01)

Altering the intracellular trafficking of Necator americanus GST-1 antigen yields novel hookworm mRNA vaccine candidates.
by: Athos Silva De Oliveira, et al.
Published: (2025-01-01)

Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023
by: Siqi Zhang, et al.
Published: (2025-12-01)

Next-generation ctDNA-driven clinical trials in precision immuno-oncology
by: Charu Aggarwal, et al.
Published: (2023-01-01)

The role of SAGA in the transcription and export of mRNA
by: E. N. Nabirochkina, et al.
Published: (2019-03-01)

Translational inhalable extracellular vesicle‐based mRNA therapy for the treatment of lung cancer
by: Mengrui Liu, et al.
Published: (2025-01-01)

A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
by: Mengyuan Liu, et al.
Published: (2025-01-01)

Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
by: Qi Ma, et al.
Published: (2025-01-01)

A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features
by: Zihan Quan, et al.
Published: (2025-12-01)

Transcription Expression and Clinical Significance of Dishevelled-3 mRNA and δ-Catenin mRNA in Pleural Effusions from Patients with Lung Cancer
by: Xiao-Yan Li, et al.
Published: (2012-01-01)

BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancer
by: Amnuay Kleebayoon, et al.
Published: (2023-12-01)

tRNA/mRNA Mimicry by tmRNA and SmpB in Trans-Translation
by: Daisuke Kurita, et al.
Published: (2011-01-01)

FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis
by: Amaya Lopez-Pascual, et al.
Published: (2025-01-01)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01)

Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research
by: Cheol-Kyu Park, MD, PhD, et al.
Published: (2025-03-01)

Teaching an old dog new tricks: re-engineering IL-2 for immuno-oncology applications
by: Mario Sznol, et al.
Published: (2023-01-01)

Germ granule-mediated mRNA storage and translational control
by: Hoang-Anh Pham-Bui, et al.
Published: (2025-12-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
by: Amparo L. Figueroa, et al.
Published: (2025-12-01)

Editorial: Building public confidence in innovative mRNA vaccines
by: Jia Hu, et al.
Published: (2025-01-01)

Analysis of Several PLA2 mRNA in Human Meningiomas
by: Yves Denizot, et al.
Published: (2009-01-01)

Effects of Ginseng and Echinacea on Cytokine mRNA Expression in Rats
by: Deniz Uluışık, et al.
Published: (2012-01-01)

Nonviral targeted mRNA delivery: principles, progresses, and challenges
by: Xi He, et al.
Published: (2025-01-01)

Rel mRNA 和 NF- κB2 mRNA 在人肝细胞癌中的表达及其临床意义
Published: (2006-01-01)

Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges
by: Ting Zhang, et al.
Published: (2025-12-01)

Decreases in mRNA by an siRNA Complex Do not Alter Blood Pressure in Mice
by: Su-Min Ji, et al.
Published: (2012-03-01)

Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson’s Disease
by: Xi Yin, et al.
Published: (2022-01-01)

Identification of the circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Bioinformatics Analysis
by: Jiancheng Lv, et al.
Published: (2021-01-01)

Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery
by: Wei Wang, et al.
Published: (2024-12-01)

CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA
by: Zachary F. Mandell, et al.
Published: (2025-03-01)

GENE EXPRESSION AND mRNA SECONDARY STRUCTURES IN DIFFERENT Mycoplasma SPECIES
by: V. S. Sokolov, et al.
Published: (2015-01-01)

Complex Inflammation mRNA-Related Response in ALS Is Region Dependent
by: Sara Berjaoui, et al.
Published: (2015-01-01)

Genetic Variations and mRNA Expression of NRF2 in Parkinson’s Disease
by: Caroline Ran, et al.
Published: (2017-01-01)

腹水COX-2 mRNA的表达及意义
Published: (2016-01-01)

mRNA vaccines in the context of cancer treatment: from concept to application
by: Qiang Fu, et al.
Published: (2025-01-01)

Phosphorylation of a nuclear condensate regulates cohesion and mRNA retention
by: Alexa B. R. McIntyre, et al.
Published: (2025-01-01)

Deciphering the role of miRNA-mRNA interactions in cerebral vasospasm post intracranial hemorrhage
by: Xiang Chu, et al.
Published: (2025-02-01)

mRNA-lncRNA gene expression signature in HPV-associated neoplasia and cervical cancer
by: E. D. Kulaeva, et al.
Published: (2024-05-01)